NYSE:PFE
Pfizer
- Stock
industry
Drug Manufacturers / Generalexchange
New York Stock Exchangewebsite
www.pfizer.comipo date
Jan 17, 1944full time employees
83,000currency
USD
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small mol...Show More
Earnings
Earnings per Share (Estimate*)
Revenue (Estimate*)
*Estimate based on analyst consensus
founders
- Christina Warren
- Kyung Ae Lee
- Thomas A Wynn
investments
Money Raised | Funding Round | Lead Investor | Announced Date | Organization Name |
---|---|---|---|---|
$37.4M | Venture Round - EvolveImmune Therapeutics | — | 16-11-2023 | EvolveImmune Therapeutics |
€94.9M | Series C - AgomAb Therapeutics | — | 11-10-2023 | AgomAb Therapeutics |
$25M | Corporate Round - CellCentric | Yes | 11-07-2023 | CellCentric |
$25M | Post-IPO Equity - Caribou Biosciences | Yes | 29-06-2023 | Caribou Biosciences |
$106.5M | Series E - Vedanta Biosciences | — | 25-04-2023 | Vedanta Biosciences |
$25M | Post-IPO Equity - ORIC Pharmaceuticals | Yes | 21-12-2022 | ORIC Pharmaceuticals |
$60M | Series C - Carrick Therapeutics | Yes | 01-12-2022 | Carrick Therapeutics |
$20M | Corporate Round - CytoReason | Yes | 20-09-2022 | CytoReason |
€90.5M | Post-IPO Equity - Valneva | Yes | 20-06-2022 | Valneva |
$65M | Series B - Dren Bio | — | 14-06-2022 | Dren Bio |
acquisitions
Price | Acquiree Name | Announced Date | Transaction Name |
---|---|---|---|
$43B | Seagen | 13-03-2023 | Seagen acquired by Pfizer |
$5.4B | Global Blood Therapeutics | 08-08-2022 | Global Blood Therapeutics acquired by Pfizer |
$11.6B | Biohaven Pharmaceutical | 10-05-2022 | Biohaven Pharmaceutical acquired by Pfizer |
A$179M | ResApp Health | 15-04-2022 | ResApp Health acquired by Pfizer |
$525M | ReViral | 07-04-2022 | ReViral acquired by Pfizer |
$6.7M | Arena Pharmaceuticals | 13-12-2021 | Arena Pharmaceuticals acquired by Pfizer |
$2.3B | Trillium Therapeutics | 23-08-2021 | Trillium Therapeutics acquired by Pfizer |
— | Amplyx Pharmaceuticals | 28-04-2021 | Amplyx Pharmaceuticals acquired by Pfizer |
$11.4B | Array BioPharma | 17-06-2019 | Array BioPharma acquired by Pfizer |
$340M | Therachon | 08-05-2019 | Therachon acquired by Pfizer |
num employees
- 10001+
funding rounds
Money Raised | Announced Date | Lead Investors | Transaction Name | Number of Investors |
---|---|---|---|---|
$31B | 16-05-2023 | — | Post-IPO Debt - Pfizer | — |